BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38350547)

  • 1. S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway.
    Chen T; Ruan Y; Ji L; Cai J; Tong M; Xue Y; Zhao H; Cai X; Xu J
    Cancer Lett; 2024 Apr; 587():216709. PubMed ID: 38350547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.
    Zhou CF; Ma J; Huang L; Yi HY; Zhang YM; Wu XG; Yan RM; Liang L; Zhong M; Yu YH; Wu S; Wang W
    Oncogene; 2019 Feb; 38(8):1256-1268. PubMed ID: 30254211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
    Tobler NE; Detmar M
    J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.
    Zheng H; Chen C; Luo Y; Yu M; He W; An M; Gao B; Kong Y; Ya Y; Lin Y; Li Y; Xie K; Huang J; Lin T
    Clin Transl Med; 2021 Jul; 11(7):e497. PubMed ID: 34323412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
    Ishii H; Yazawa T; Sato H; Suzuki T; Ikeda M; Hayashi Y; Takanashi Y; Kitamura H
    Lung Cancer; 2004 Sep; 45(3):325-37. PubMed ID: 15301873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.
    Chen C; Luo Y; He W; Zhao Y; Kong Y; Liu H; Zhong G; Li Y; Li J; Huang J; Chen R; Lin T
    J Clin Invest; 2020 Jan; 130(1):404-421. PubMed ID: 31593555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.
    Zheng S; Shen H; Jia Q; Jing C; Lin J; Zhang M; Zhang X; Zhang B; Liu Y
    Future Oncol; 2017 Oct; 13(23):2053-2063. PubMed ID: 28984474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma.
    Thelen A; Scholz A; Benckert C; von Marschall Z; Schröder M; Wiedenmann B; Neuhaus P; Rosewicz S; Jonas S
    Int J Cancer; 2008 Jun; 122(11):2471-81. PubMed ID: 18338756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
    World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.
    Li Z; Tang M; Ling B; Liu S; Zheng Y; Nie C; Yuan Z; Zhou L; Guo G; Tong A; Wei Y
    J Mol Med (Berl); 2014 Mar; 92(3):291-303. PubMed ID: 24281831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.
    Kitano H; Chung JY; Noh KH; Lee YH; Kim TW; Lee SH; Eo SH; Cho HJ; Choi CH; Inoue S; Hanaoka J; Fukuoka J; Hewitt SM
    J Transl Med; 2017 Jun; 15(1):138. PubMed ID: 28623914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma.
    Liu T; Li P; Li J; Qi Q; Sun Z; Shi S; Xie Y; Liu S; Wang Y; Du L; Wang C
    Mol Ther Oncolytics; 2021 Dec; 23():163-180. PubMed ID: 34729394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
    Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
    Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal carcinoma cell-excreted exosomal uc.189 promotes lymphatic metastasis.
    Ding Z; Yan Y; Guo YL; Wang C
    Aging (Albany NY); 2021 May; 13(10):13846-13858. PubMed ID: 34024769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
    Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
    Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.